TITLE

EGF vaccine safe, effective in patients with NSCLC

AUTHOR(S)
Jacob, Harry S.
PUB. DATE
April 2008
SOURCE
Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p28
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on research on Epidermal growth factor (EGF) in patients with non-small cell lung cancer (NSCLC). According to research in Cuba on the immunogenicity, effect on survival and safety of EGF-based cancer vaccine on 80 patients with advanced NSCLC. Findings showed that the vaccine was safe and related to increased survival rate.
ACCESSION #
31705861

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics